0001567619-21-019427.txt : 20211105
0001567619-21-019427.hdr.sgml : 20211105
20211105185930
ACCESSION NUMBER: 0001567619-21-019427
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211104
FILED AS OF DATE: 20211105
DATE AS OF CHANGE: 20211105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dummer Wolfgang
CENTRAL INDEX KEY: 0001749991
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29889
FILM NUMBER: 211386078
MAIL ADDRESS:
STREET 1: 5491 OPTICAL CT.
CITY: SAN JOSE
STATE: CA
ZIP: 95138
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RIGEL PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001034842
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943248524
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1180 VETERANS BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
MAIL ADDRESS:
STREET 1: 1180 VETERANS BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc1.xml
FORM 4
X0306
4
2021-11-04
0
0001034842
RIGEL PHARMACEUTICALS INC
RIGL
0001749991
Dummer Wolfgang
RIGEL PHARMACEUTICALS, INC.
1180 VETERANS BLVD.
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
EVP & CMO
Stock Option (Right to Buy)
2.38
2021-11-04
4
A
0
37500
0
A
2030-08-25
Common Stock
37500
37500
D
The reporting person was granted a performance-based option to purchase 37,500 shares of common stock on August 25, 2020. Thus, the exercise price of this option is $2.38 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On November 4, 2021, it was determined that the performance metric had been met.
The shares of common stock subject to the option vest in equal monthly installments over twenty-four (24) months from the vesting commencement date of October 25, 2021, subject to the reporting person's continuous service to the issuer through each such period.
/s/ Dolly Vance (Attorney-in-Fact)
2021-11-05